These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ticrynafen in anephric patients: effects on uric acid and pharmacokinetics.
    Author: Murray TG, Brown S, Dubb JW, Hwang BY, Stote RM.
    Journal: Clin Pharmacol Ther; 1980 May; 27(5):686-9. PubMed ID: 7371365.
    Abstract:
    Ticrynafen was given to 6 anephric patients undergoing maintenance hemodialysis. Ticrynafen was given daily for the 3 days between hemodialyses. Ticrynafen had no effect on the interdialysis rise in serum uric acid levels. Ticrynafen did not accumulate in serum, but levels of metabolites continued to rise over the 3 days. Hemodialysis (5 hr) reduced levels of ticrynafen by 38% but had less effect on metabolite levels. There was no effect on serum cholesterol or triglycerides.
    [Abstract] [Full Text] [Related] [New Search]